Year: 2024

LOS ANGELES, Oct. 22, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX:EGLX) will report financial and operating results for its third quarter ending September 30, 2024, on Thursday, November 14, 2024, after the market closes. Management will host a conference call and webcast that same day at 5:00 p.m. ET. Conference call details:Toll Free: 1-855-239-1101 or or 1-412-317-5231 Passcode: 7399570; or ‘Call me’ link: https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNQ==   Live Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1694548&tp_key=e0a4b40fa4A replay of the webcast will be available on the Investor Relations page of the Enthusiast Gaming website, enthusiastgaming.com/investors. About Enthusiast Gaming Enthusiast Gaming is...

BEIJING, Oct. 22, 2024 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, announced today the release of an AIGC miniseries Outlaws of the Marsh by CHEERS Telepathy, offering a reinterpretation of the Chinese classic novel whilst stayed true to its original. The series is currently available on platforms such as TikTok, Tencent Video, Little Red Book, Kuaishou, and Weibo, with one new episode aired every Wednesday. You may also find the latest updates via the Outlaws of the Marsh channel at http://www.gsmg.co/AI-Show/shuihuzhuan/index.html. A perfect integration of technology and culture As a company with profound experience in the field of media technology innovation, Cheer Holding has once again turned its attention...

New non-human primate data show highly selective in vivo delivery of mRNA to T cells with a cell-targeted lipid nanoparticle (ctLNP)CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today presented data on its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress. The company presented data showing that a single IV dose of its ctLNP delivered mRNA encoding a reporter protein to a majority of circulating T cells in non-human primates (NHPs). In the study, conducted as part of Generation Bio’s partnership with Moderna, Inc., NHPs received a single 1 mg/kg dose of ctLNP-mRNA, which transduced...

HAMPTON, N.H., Oct. 22, 2024 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its third quarter 2024 earnings after the market closes on November 4, 2024. Unitil will host its conference call and webcast on November 5, 2024 at 10:00 a.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably...

MELBOURNE, Australia, Oct. 22, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma1, which has the mission of expanding global access to innovative radiopharmaceuticals for cancer imaging and treatment using two generator-produced isotopes, technetium-99m (99mTc) and rhenium-188 (188Re). Rhine Pharma was formed following a collaboration between Telix and Heidelberg University Hospital (UKHD), which aimed to develop a PSMA2-targeting small molecule that could be labelled with either 99mTc for SPECT3 imaging, or 188Re for radioligand therapy. The collaboration successfully created a potential next-generation theranostic compound, RHN0014, which Rhine Pharma is now advancing into a novel Phase I/IIa theranostic clinical study (the ‘RHINO Trial’), exploring...

SINGAPORE, Oct. 22, 2024 (GLOBE NEWSWIRE) — BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a fast-growing digital asset mining service and world-leading cloud-mining service provider, today announced it has entered into a definitive agreement to acquire a majority stake in an 80-megawatt (MW) Bitcoin mining facility in Ethiopia. This transaction marks the start of the Company’s transition from an asset-light strategy to one that manages a diverse and robust portfolio of Bitcoin mining infrastructure. As of June 30, 2024, BitFuFu’s hosting capacity was 522 MW, all of which is hosted by third parties. Upon completion of this transaction, BitFuFu’s hosting capacity will surpass the 600MW mark, approximately 13% of which will reside in sites owned and operated by the Company. The newly acquired mining facility will provide...

Highlights:In 9m 2024, hard rock gold production amounted to 328.2 kg (10,550 oz), compared to 503.3 kg (16,182 oz) in 9m 2023, a decrease of 35%, or 175.2 kg (5,631 oz); Alluvial gold production amounted to 37.2 kg (1,195 oz) compared to 14.8 kg (476 oz) an increase of 151%, or 22.4 kg (719 oz); In 9m 2024, total gold sales were 403.0 kg (12,956 oz), compared to 438.5 kg (14,097 oz) in 9m 2023, a decrease of 35.5 kg (1,141 oz), or 8%; 299,003 tonnes of ore with average grade of 1.22 g/t were processed through the CIL plant; 120,790 tonnes of ore were mined in 9m 2024, compared to 175,902 tonnes in 9m 2023, a decrease of 55,112 tonnes or 31%. Stripping volume amounted to 2,180,600 m3 compared to 1,649,600 m3, an increase of 531,000 m3 or 32%; The average grade in the ore mined in 9m 2024 was 1.62 g/t, compared to 2.45 g/t in 9m 2023,...

To give an overview of the 2024 Q3 and nine month financial results, LHV Group organised an investor meeting webinar on 22 October. An overview of the company’s progress was given by Madis Toomsalu, Chairman of the Management Board of LHV Group and Meelis Paakspuu, CFO of LHV Group. The live coverage was followed by 38 participants, the live feed of the presentation was broadcast over Zoom. Recording of the investor meeting (in Estonian) is available at: https://youtu.be/JCNtp004Z48  LHV Group is the largest domestic financial group and capital provider in Estonia. The LHV Group’s key subsidiaries are LHV Pank, LHV Varahaldus, LHV Kindlustus, and LHV Bank Limited. The Group employs nearly 1,200 people. As at the end of September, LHV’s banking services are being used by 445,000 clients, the pension funds managed by LHV have 116,000...

Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company. “I would like to thank Christel for her efforts and positive contributions to HBC. I wish her all the best of luck in her future endeavors” said Jon Olav Ødegård, CEO of HBC. HBC has initiated a search for Kanli’s successor for the CFO position. Contact details for further information:Jon Olav Ødegård, CEOE-mail: joo@hofsethbiocare.no This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Jon Olav Ødegård, CEO, on the time set out above, on behalf of HBC.